Drugs that contain Estradiol Acetate
1. Femring patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5855906 | MILLICENT | Intravaginal drug delivery devices for the administration of 17β-oestradiol precursors |
Dec, 2015
(8 years ago) | |
Market Authorisation Date: 20 March, 2003
Treatment: Method of releasing 17-beta oestradiol precursor in a substantially zero order pattern for at least three weeks
Dosage: INSERT, EXTENDED RELEASE;VAGINAL
More Information on Dosage
FEMRING family patents
2. Femtrace patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7799771 | APIL | Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
Dec, 2021
(2 years ago) | |
| US6962908 | APIL | Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
Dec, 2021
(2 years ago) | |
| US7572779 | APIL | Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
Oct, 2025
(1 year, 5 months from now) | |
Market Authorisation Date: 20 August, 2004
Treatment: Treatment of moderate to severe vasomotor symptoms associated with menopause
Dosage: TABLET;ORAL
More Information on Dosage
FEMTRACE family patents